Jeffrey J. Ishizuka

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Brian C. Miller, Debattama R. Sen, Rose Al Abosy et al. · Nature Immunology · 2019 · 1.9K citations · Full text

Mediate Tumor Control, Cancer Immunosurveillance, Immunology +8

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

Jeffrey J. Ishizuka, Robert T. Manguso, Collins Cheruiyot et al. · Nature · 2018 · 688 citations · Full text

Cancer Immunosurveillance, Tumours Overcomes Resistance, Medicine +8

Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity

Gabriel K. Griffin, Jingyi Wu, Arvin Iracheta‐Vellve et al. · Nature · 2021 · 339 citations · Full text

Epigenetic Silencing, Cancer Immunosurveillance, Immunology +6

Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer

Panagiotis A. Konstantinopoulos, Weixiu Luo, Joyce F. Liu et al. · Journal of Clinical Oncology · 2019 · 211 citations · Full text

The Structural Dynamics and Energetics of an Immunodominant T Cell Receptor Are Programmed by Its Vβ Domain

Jeffrey J. Ishizuka, Guillaume B. E. Stewart-Jones, Anton van der Merwe et al. · Immunity · 2008 · 112 citations · Full text

Engineering, Adaptive Immune System, Structural Dynamics +16